Advertisement

Index by author

January 01, 1991; Volume 19,Issue 1

A

  1. Anders, M W

    1. Biosynthesis and biliary excretion of S-conjugates of hexachlorobuta-1,3-diene in the perfused rat liver.
      Y S Gietl and M W Anders
      Drug Metabolism and Disposition January 1991, 19 (1) 274-277;

B

  1. Bäckström, R

    1. Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine.
      J Taskinen, T Wikberg, P Ottoila, L Kanner, T Lotta, A Pippuri and R Bäckström
      Drug Metabolism and Disposition January 1991, 19 (1) 178-183;

  2. Ball, T

    1. Pharmacokinetics and metabolism of triclopyr in the crayfish (Procambarus clarki).
      M G Barron, S C Hansen and T Ball
      Drug Metabolism and Disposition January 1991, 19 (1) 163-167;

  3. Barbhaiya, R H

    1. Disposition of the cephalosporin cefepime in normal and renally impaired subjects.
      R H Barbhaiya, C A Knupp, S T Forgue, G R Matzke, C E Halstenson, J A Opsahl and K A Pittman
      Drug Metabolism and Disposition January 1991, 19 (1) 68-73;

  4. Barron, M G

    1. Pharmacokinetics and metabolism of triclopyr in the crayfish (Procambarus clarki).
      M G Barron, S C Hansen and T Ball
      Drug Metabolism and Disposition January 1991, 19 (1) 163-167;

  5. Bélanger, P M

    1. Temporal variations in microsomal lipid peroxidation and in glutathione concentration of rat liver.
      P M Bélanger, M Desgagné and B Bruguerolle
      Drug Metabolism and Disposition January 1991, 19 (1) 241-244;

  6. Bellemare, M

    1. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.
      S Marleau, T T Nguyen, P Du Souich, M Bellemare, A De Lean and H Ong
      Drug Metabolism and Disposition January 1991, 19 (1) 194-199;

  7. Benet, L Z

    1. Prednisolone and prednisone exhibit linear extraction in the perfused rabbit liver.
      V G Hale and L Z Benet
      Drug Metabolism and Disposition January 1991, 19 (1) 87-93;

  8. Bernstein, J R

    1. Observations on the absorption, distribution, metabolism, and excretion of the dopamine (D2) agonist, quinelorane, in rats, mice, dogs, and monkeys.
      B M Manzione, J R Bernstein and R B Franklin
      Drug Metabolism and Disposition January 1991, 19 (1) 54-60;

  9. Bickel, M H

    1. Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. II. Benzodiazepines.
      X Xie, S H Steiner and M H Bickel
      Drug Metabolism and Disposition January 1991, 19 (1) 15-19;
    2. Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. I. Barbiturates.
      S H Steiner, M J Moor and M H Bickel
      Drug Metabolism and Disposition January 1991, 19 (1) 8-14;

  10. Bogdanffy, M S

    1. Metabolism of dibasic esters by rat nasal mucosal carboxylesterase.
      M S Bogdanffy, C R Kee, C A Hinchman and B A Trela
      Drug Metabolism and Disposition January 1991, 19 (1) 124-129;

  11. Bories, G F

    1. Evidence for glucuronidation and sulfation of zeranol and metabolites (taleranol and zearalanone) by rat and pig hepatic subfractions.
      G F Bories, E F Perdu-Durand, J F Sutra and J E Tulliez
      Drug Metabolism and Disposition January 1991, 19 (1) 140-143;

  12. Boudinot, F D

    1. Effects of age and dose on the pharmacokinetics of ibuprofen in the rat.
      J H Satterwhite and F D Boudinot
      Drug Metabolism and Disposition January 1991, 19 (1) 61-67;

  13. Bowen, J M

    1. Metabolism and disposition of sulfluramid, a unique polyfluorinated insecticide, in the rat.
      R O Manning, J V Bruckner, M E Mispagel and J M Bowen
      Drug Metabolism and Disposition January 1991, 19 (1) 205-211;

  14. Boyer, C S

    1. The metabolism of 3,7-dimethyl-2,6-octadienal (citral) in rat hepatic mitochondrial and cytosolic fractions. Interactions with aldehyde and alcohol dehydrogenases.
      C S Boyer and D R Petersen
      Drug Metabolism and Disposition January 1991, 19 (1) 81-86;

  15. Browne, J L

    1. Chronic stress impairs oxidative metabolism and hepatic excretion of model xenobiotic substrates in the rat.
      G M Pollack, J L Browne, J Marton and L J Haberer
      Drug Metabolism and Disposition January 1991, 19 (1) 130-134;

  16. Bruckner, J V

    1. Metabolism and disposition of sulfluramid, a unique polyfluorinated insecticide, in the rat.
      R O Manning, J V Bruckner, M E Mispagel and J M Bowen
      Drug Metabolism and Disposition January 1991, 19 (1) 205-211;

  17. Bruguerolle, B

    1. Temporal variations in microsomal lipid peroxidation and in glutathione concentration of rat liver.
      P M Bélanger, M Desgagné and B Bruguerolle
      Drug Metabolism and Disposition January 1991, 19 (1) 241-244;

  18. Brunn, G J

    1. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
      P R Pentel, D E Keyler, G J Brunn, J M Milavetz, D G Gilbertson, S G Matta and S M Pond
      Drug Metabolism and Disposition January 1991, 19 (1) 24-28;

C

  1. Chan, K K

    1. Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat.
      P S Hong, A Srigritsanapol and K K Chan
      Drug Metabolism and Disposition January 1991, 19 (1) 1-7;

  2. Cheng, H

    1. Disposition and metabolism of the angiotensin-converting enzyme inhibitor [4S-[4 alpha, 7 alpha, (R*), 12b beta]]-7-[S-(1-ethoxycarbonyl-3- phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo- pyrido[2,1-a][2]benzazepine-4-carboxylic acid in monkeys and dogs.
      H Cheng, J D Stuhler, B R Dorrbecker and W P Gordon
      Drug Metabolism and Disposition January 1991, 19 (1) 212-217;

  3. Clark, V

    1. The enzymatic hydrolysis-activation of the adriamycin cardioprotective agent (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane.
      B B Hasinoff, F X Reinders and V Clark
      Drug Metabolism and Disposition January 1991, 19 (1) 74-80;

  4. Cleveland, P A

    1. Dose-dependent and time-dependent pharmacokinetics in the dog after intravenous administration of dextrorphan.
      P A Cleveland, S Teller, V Kachevsky, E Pinili, R Evans and M W Modi
      Drug Metabolism and Disposition January 1991, 19 (1) 245-250;

  5. Connolly, R B

    1. Gastrointestinal absorption of xenobiotics in physiologically based pharmacokinetic models. A two-compartment description.
      D A Staats, J W Fisher and R B Connolly
      Drug Metabolism and Disposition January 1991, 19 (1) 144-148;

  6. Cooper, J K

    1. Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugates.
      C J Jackson, J W Hubbard, G McKay, J K Cooper, E M Hawes and K K Midha
      Drug Metabolism and Disposition January 1991, 19 (1) 188-193;

D

  1. Daher, G C

    1. Circadian variation of fluoropyrimidine catabolic enzymes in rat liver: possible relevance to 5-fluorodeoxyuridine chemotherapy.
      G C Daher, R W Zhang, S J Soong and R B Diasio
      Drug Metabolism and Disposition January 1991, 19 (1) 285-287;

  2. De Lean, A

    1. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.
      S Marleau, T T Nguyen, P Du Souich, M Bellemare, A De Lean and H Ong
      Drug Metabolism and Disposition January 1991, 19 (1) 194-199;

  3. Desgagné, M

    1. Temporal variations in microsomal lipid peroxidation and in glutathione concentration of rat liver.
      P M Bélanger, M Desgagné and B Bruguerolle
      Drug Metabolism and Disposition January 1991, 19 (1) 241-244;

  4. De Zeeuw, R A

    1. Glucuronidation of labetalol at the two hydroxy positions by bovine liver microsomes. Isolation, purification, and structure elucidation of the glucuronides of labetalol.
      N R Niemeijer, T K Gerding and R A De Zeeuw
      Drug Metabolism and Disposition January 1991, 19 (1) 20-23;

  5. Diasio, R B

    1. Circadian variation of fluoropyrimidine catabolic enzymes in rat liver: possible relevance to 5-fluorodeoxyuridine chemotherapy.
      G C Daher, R W Zhang, S J Soong and R B Diasio
      Drug Metabolism and Disposition January 1991, 19 (1) 285-287;

  6. DiBiasio, K W

    1. Xenobiotic metabolizing enzyme activities in rat, mouse, monkey, and human testes.
      K W DiBiasio, M H Silva, L R Shull, J W Overstreet, B D Hammock and M G Miller
      Drug Metabolism and Disposition January 1991, 19 (1) 227-232;

  7. Domino, E F

    1. Genetic polymorphism of cytochrome P-450-dependent phencyclidine hydroxylation in mice. Comparison of phencyclidine hydroxylation in humans.
      E J Holsztynska, W W Weber and E F Domino
      Drug Metabolism and Disposition January 1991, 19 (1) 48-53;

  8. Dorrbecker, B R

    1. Disposition and metabolism of the angiotensin-converting enzyme inhibitor [4S-[4 alpha, 7 alpha, (R*), 12b beta]]-7-[S-(1-ethoxycarbonyl-3- phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo- pyrido[2,1-a][2]benzazepine-4-carboxylic acid in monkeys and dogs.
      H Cheng, J D Stuhler, B R Dorrbecker and W P Gordon
      Drug Metabolism and Disposition January 1991, 19 (1) 212-217;

  9. Du Souich, P

    1. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.
      S Marleau, T T Nguyen, P Du Souich, M Bellemare, A De Lean and H Ong
      Drug Metabolism and Disposition January 1991, 19 (1) 194-199;

E

  1. Eckerson, H W

    1. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
      K N Gan, A Smolen, H W Eckerson and B N La Du
      Drug Metabolism and Disposition January 1991, 19 (1) 100-106;
    2. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
      A Smolen, H W Eckerson, K N Gan, N Hailat and B N La Du
      Drug Metabolism and Disposition January 1991, 19 (1) 107-112;

  2. Eichelbaum, M

    1. Identification of thiodiglycolic acid, thiodiglycolic acid sulfoxide, and (3-carboxymethylthio)lactic acid as major human biotransformation products of S-carboxymethyl-L-cysteine.
      U Hofmann, M Eichelbaum, S Seefried and C O Meese
      Drug Metabolism and Disposition January 1991, 19 (1) 222-226;

  3. Estep, J E

    1. [14C]monocrotaline kinetics and metabolism in the rat.
      J E Estep, M W Lamé, D Morin, A D Jones, D W Wilson and H J Segall
      Drug Metabolism and Disposition January 1991, 19 (1) 135-139;

  4. Evans, R

    1. Dose-dependent and time-dependent pharmacokinetics in the dog after intravenous administration of dextrorphan.
      P A Cleveland, S Teller, V Kachevsky, E Pinili, R Evans and M W Modi
      Drug Metabolism and Disposition January 1991, 19 (1) 245-250;

F

  1. Faurie, M

    1. Biodistribution and metabolism in rats and mice of bucromarone.
      J C Maurizis, C Nicolas, M Verny, M Ollier, M Faurie, M Payard and A Veyre
      Drug Metabolism and Disposition January 1991, 19 (1) 94-99;

  2. Fisher, J W

    1. Gastrointestinal absorption of xenobiotics in physiologically based pharmacokinetic models. A two-compartment description.
      D A Staats, J W Fisher and R B Connolly
      Drug Metabolism and Disposition January 1991, 19 (1) 144-148;

  3. Forgue, S T

    1. Disposition of the cephalosporin cefepime in normal and renally impaired subjects.
      R H Barbhaiya, C A Knupp, S T Forgue, G R Matzke, C E Halstenson, J A Opsahl and K A Pittman
      Drug Metabolism and Disposition January 1991, 19 (1) 68-73;

  4. Franklin, R B

    1. Observations on the absorption, distribution, metabolism, and excretion of the dopamine (D2) agonist, quinelorane, in rats, mice, dogs, and monkeys.
      B M Manzione, J R Bernstein and R B Franklin
      Drug Metabolism and Disposition January 1991, 19 (1) 54-60;

G

  1. Gan, K N

    1. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
      K N Gan, A Smolen, H W Eckerson and B N La Du
      Drug Metabolism and Disposition January 1991, 19 (1) 100-106;
    2. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
      A Smolen, H W Eckerson, K N Gan, N Hailat and B N La Du
      Drug Metabolism and Disposition January 1991, 19 (1) 107-112;

  2. Garteiz, D

    1. In vitro and in vivo murine metabolism of spirogermanium.
      D Garteiz, Z H Siddik and R A Newman
      Drug Metabolism and Disposition January 1991, 19 (1) 44-47;

  3. Gerding, T K

    1. Glucuronidation of labetalol at the two hydroxy positions by bovine liver microsomes. Isolation, purification, and structure elucidation of the glucuronides of labetalol.
      N R Niemeijer, T K Gerding and R A De Zeeuw
      Drug Metabolism and Disposition January 1991, 19 (1) 20-23;

  4. Gietl, Y S

    1. Biosynthesis and biliary excretion of S-conjugates of hexachlorobuta-1,3-diene in the perfused rat liver.
      Y S Gietl and M W Anders
      Drug Metabolism and Disposition January 1991, 19 (1) 274-277;

  5. Gilbertson, D G

    1. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
      P R Pentel, D E Keyler, G J Brunn, J M Milavetz, D G Gilbertson, S G Matta and S M Pond
      Drug Metabolism and Disposition January 1991, 19 (1) 24-28;

  6. Gordon, W P

    1. Disposition and metabolism of the angiotensin-converting enzyme inhibitor [4S-[4 alpha, 7 alpha, (R*), 12b beta]]-7-[S-(1-ethoxycarbonyl-3- phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo- pyrido[2,1-a][2]benzazepine-4-carboxylic acid in monkeys and dogs.
      H Cheng, J D Stuhler, B R Dorrbecker and W P Gordon
      Drug Metabolism and Disposition January 1991, 19 (1) 212-217;

  7. Guttendorf, R J

    1. Stereoselective differences in propranolol disposition in female Sprague-Dawley and Dark Agouti rats.
      R J Guttendorf, H B Kostenbauder and P J Wedlund
      Drug Metabolism and Disposition January 1991, 19 (1) 251-256;

H

  1. Haberer, L J

    1. Chronic stress impairs oxidative metabolism and hepatic excretion of model xenobiotic substrates in the rat.
      G M Pollack, J L Browne, J Marton and L J Haberer
      Drug Metabolism and Disposition January 1991, 19 (1) 130-134;

  2. Hahn, M E

    1. Immunohistochemical localization of cytochrome P-450IA1 induced by 3,3',4,4'-tetrachlorobiphenyl and by 2,3,7,8-tetrachlorodibenzoafuran in liver and extrahepatic tissues of the teleost Stenotomus chrysops (scup).
      R M Smolowitz, M E Hahn and J J Stegeman
      Drug Metabolism and Disposition January 1991, 19 (1) 113-123;

  3. Hailat, N

    1. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
      A Smolen, H W Eckerson, K N Gan, N Hailat and B N La Du
      Drug Metabolism and Disposition January 1991, 19 (1) 107-112;

  4. Hale, V G

    1. Prednisolone and prednisone exhibit linear extraction in the perfused rabbit liver.
      V G Hale and L Z Benet
      Drug Metabolism and Disposition January 1991, 19 (1) 87-93;

  5. Hall, S D

    1. Stereoselective hydrolysis of flurbiprofen conjugates.
      M P Knadler and S D Hall
      Drug Metabolism and Disposition January 1991, 19 (1) 280-282;

  6. Hallak, H O

    1. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats.
      H O Hallak and P J Wedlund
      Drug Metabolism and Disposition January 1991, 19 (1) 278-279;

  7. Halstenson, C E

    1. Disposition of the cephalosporin cefepime in normal and renally impaired subjects.
      R H Barbhaiya, C A Knupp, S T Forgue, G R Matzke, C E Halstenson, J A Opsahl and K A Pittman
      Drug Metabolism and Disposition January 1991, 19 (1) 68-73;

  8. Hammock, B D

    1. Xenobiotic metabolizing enzyme activities in rat, mouse, monkey, and human testes.
      K W DiBiasio, M H Silva, L R Shull, J W Overstreet, B D Hammock and M G Miller
      Drug Metabolism and Disposition January 1991, 19 (1) 227-232;

  9. Hansen, S C

    1. Pharmacokinetics and metabolism of triclopyr in the crayfish (Procambarus clarki).
      M G Barron, S C Hansen and T Ball
      Drug Metabolism and Disposition January 1991, 19 (1) 163-167;

  10. Hasinoff, B B

    1. The enzymatic hydrolysis-activation of the adriamycin cardioprotective agent (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane.
      B B Hasinoff, F X Reinders and V Clark
      Drug Metabolism and Disposition January 1991, 19 (1) 74-80;

  11. Hawes, E M

    1. Cis-flupentixol metabolites in rat plasma and bile. The first proof of glutathione conjugation at the exocyclic double bond.
      Y Z Shu, J W Hubbard, G McKay, E M Hawes and K K Midha
      Drug Metabolism and Disposition January 1991, 19 (1) 154-162;
    2. Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugates.
      C J Jackson, J W Hubbard, G McKay, J K Cooper, E M Hawes and K K Midha
      Drug Metabolism and Disposition January 1991, 19 (1) 188-193;

  12. Heykants, J

    1. Study of the placental transfer of cisapride in sheep. Plasma levels in the pregnant ewe, the fetus, and the lamb.
      G Veereman-Wauters, J Monbaliu, W Meuldermans, R Woestenborghs, M Verlinden, J Heykants and C D Rudolph
      Drug Metabolism and Disposition January 1991, 19 (1) 168-172;

  13. Hinchman, C A

    1. Metabolism of dibasic esters by rat nasal mucosal carboxylesterase.
      M S Bogdanffy, C R Kee, C A Hinchman and B A Trela
      Drug Metabolism and Disposition January 1991, 19 (1) 124-129;

  14. Hinson, J A

    1. Mechanism of acetaminophen-stimulated NADPH oxidation catalyzed by the peroxidase-H2O2 system.
      R J Keller and J A Hinson
      Drug Metabolism and Disposition January 1991, 19 (1) 184-187;

  15. Hirahashi, N

    1. Mouse hepatic microsomal enzyme that catalyzes oxidation of 11-oxo-delta 8-tetrahydrocannabinol to delta 8-tetrahydrocannabinol-11-oic acid.
      K Watanabe, N Hirahashi, S Narimatsu, I Yamamoto and H Yoshimura
      Drug Metabolism and Disposition January 1991, 19 (1) 218-221;

  16. Hirobe, M

    1. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
      K Kikuchi, Y Nagatsu, Y Makino, T Mashino, S Ohta and M Hirobe
      Drug Metabolism and Disposition January 1991, 19 (1) 257-262;

  17. Hofmann, U

    1. Identification of thiodiglycolic acid, thiodiglycolic acid sulfoxide, and (3-carboxymethylthio)lactic acid as major human biotransformation products of S-carboxymethyl-L-cysteine.
      U Hofmann, M Eichelbaum, S Seefried and C O Meese
      Drug Metabolism and Disposition January 1991, 19 (1) 222-226;

  18. Holsztynska, E J

    1. Genetic polymorphism of cytochrome P-450-dependent phencyclidine hydroxylation in mice. Comparison of phencyclidine hydroxylation in humans.
      E J Holsztynska, W W Weber and E F Domino
      Drug Metabolism and Disposition January 1991, 19 (1) 48-53;

  19. Hong, P S

    1. Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat.
      P S Hong, A Srigritsanapol and K K Chan
      Drug Metabolism and Disposition January 1991, 19 (1) 1-7;

  20. Hubbard, J W

    1. Cis-flupentixol metabolites in rat plasma and bile. The first proof of glutathione conjugation at the exocyclic double bond.
      Y Z Shu, J W Hubbard, G McKay, E M Hawes and K K Midha
      Drug Metabolism and Disposition January 1991, 19 (1) 154-162;
    2. Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugates.
      C J Jackson, J W Hubbard, G McKay, J K Cooper, E M Hawes and K K Midha
      Drug Metabolism and Disposition January 1991, 19 (1) 188-193;

  21. Hurst, H E

    1. Studies on induction of metabolism of ethyl carbamate in mice by ethanol.
      N Kurata, H E Hurst, R A Kemper and W J Waddell
      Drug Metabolism and Disposition January 1991, 19 (1) 239-240;

I

  1. Irshaid, Y M

    1. Glucuronidation of monohydroxylated short chain bile acids by human liver microsomes and purified human liver UDP-glucuronosyltransferases.
      Y M Irshaid, A Radominska, P Zimniak, A Zimniak, R Lester and T R Tephly
      Drug Metabolism and Disposition January 1991, 19 (1) 173-177;

J

  1. Jackson, C J

    1. Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugates.
      C J Jackson, J W Hubbard, G McKay, J K Cooper, E M Hawes and K K Midha
      Drug Metabolism and Disposition January 1991, 19 (1) 188-193;

  2. Johnson, D A

    1. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.
      S P Robinson, S M Langan-Fahey, D A Johnson and V C Jordan
      Drug Metabolism and Disposition January 1991, 19 (1) 36-43;

  3. Jones, A D

    1. [14C]monocrotaline kinetics and metabolism in the rat.
      J E Estep, M W Lamé, D Morin, A D Jones, D W Wilson and H J Segall
      Drug Metabolism and Disposition January 1991, 19 (1) 135-139;

  4. Jordan, V C

    1. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.
      S P Robinson, S M Langan-Fahey, D A Johnson and V C Jordan
      Drug Metabolism and Disposition January 1991, 19 (1) 36-43;

K

  1. Kachevsky, V

    1. Dose-dependent and time-dependent pharmacokinetics in the dog after intravenous administration of dextrorphan.
      P A Cleveland, S Teller, V Kachevsky, E Pinili, R Evans and M W Modi
      Drug Metabolism and Disposition January 1991, 19 (1) 245-250;

  2. Kaneko, T

    1. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies.
      H Tanaka and T Kaneko
      Drug Metabolism and Disposition January 1991, 19 (1) 200-204;

  3. Kanner, L

    1. Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine.
      J Taskinen, T Wikberg, P Ottoila, L Kanner, T Lotta, A Pippuri and R Bäckström
      Drug Metabolism and Disposition January 1991, 19 (1) 178-183;

  4. Kee, C R

    1. Metabolism of dibasic esters by rat nasal mucosal carboxylesterase.
      M S Bogdanffy, C R Kee, C A Hinchman and B A Trela
      Drug Metabolism and Disposition January 1991, 19 (1) 124-129;

  5. Keller, R J

    1. Mechanism of acetaminophen-stimulated NADPH oxidation catalyzed by the peroxidase-H2O2 system.
      R J Keller and J A Hinson
      Drug Metabolism and Disposition January 1991, 19 (1) 184-187;

  6. Kemper, R A

    1. Studies on induction of metabolism of ethyl carbamate in mice by ethanol.
      N Kurata, H E Hurst, R A Kemper and W J Waddell
      Drug Metabolism and Disposition January 1991, 19 (1) 239-240;

  7. Keyler, D E

    1. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
      P R Pentel, D E Keyler, G J Brunn, J M Milavetz, D G Gilbertson, S G Matta and S M Pond
      Drug Metabolism and Disposition January 1991, 19 (1) 24-28;

  8. Kikuchi, K

    1. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
      K Kikuchi, Y Nagatsu, Y Makino, T Mashino, S Ohta and M Hirobe
      Drug Metabolism and Disposition January 1991, 19 (1) 257-262;

  9. Knadler, M P

    1. Stereoselective hydrolysis of flurbiprofen conjugates.
      M P Knadler and S D Hall
      Drug Metabolism and Disposition January 1991, 19 (1) 280-282;

  10. Knupp, C A

    1. Disposition of the cephalosporin cefepime in normal and renally impaired subjects.
      R H Barbhaiya, C A Knupp, S T Forgue, G R Matzke, C E Halstenson, J A Opsahl and K A Pittman
      Drug Metabolism and Disposition January 1991, 19 (1) 68-73;

  11. Kostenbauder, H B

    1. Stereoselective differences in propranolol disposition in female Sprague-Dawley and Dark Agouti rats.
      R J Guttendorf, H B Kostenbauder and P J Wedlund
      Drug Metabolism and Disposition January 1991, 19 (1) 251-256;

  12. Krause, W

    1. Comparative pharmacokinetics of abecarnil in rat following single and multiple intragastric treatment and continuous administration via the diet.
      W Krause, F Reissmann, W Schunack and C Schöbel
      Drug Metabolism and Disposition January 1991, 19 (1) 29-35;

  13. Kurata, N

    1. Studies on induction of metabolism of ethyl carbamate in mice by ethanol.
      N Kurata, H E Hurst, R A Kemper and W J Waddell
      Drug Metabolism and Disposition January 1991, 19 (1) 239-240;

L

  1. La Du, B N

    1. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
      K N Gan, A Smolen, H W Eckerson and B N La Du
      Drug Metabolism and Disposition January 1991, 19 (1) 100-106;
    2. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
      A Smolen, H W Eckerson, K N Gan, N Hailat and B N La Du
      Drug Metabolism and Disposition January 1991, 19 (1) 107-112;

  2. Lamé, M W

    1. [14C]monocrotaline kinetics and metabolism in the rat.
      J E Estep, M W Lamé, D Morin, A D Jones, D W Wilson and H J Segall
      Drug Metabolism and Disposition January 1991, 19 (1) 135-139;

  3. Langan-Fahey, S M

    1. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.
      S P Robinson, S M Langan-Fahey, D A Johnson and V C Jordan
      Drug Metabolism and Disposition January 1991, 19 (1) 36-43;

  4. Lester, R

    1. Glucuronidation of monohydroxylated short chain bile acids by human liver microsomes and purified human liver UDP-glucuronosyltransferases.
      Y M Irshaid, A Radominska, P Zimniak, A Zimniak, R Lester and T R Tephly
      Drug Metabolism and Disposition January 1991, 19 (1) 173-177;

  5. Lin, J H

    1. Dose-dependent stereopharmacokinetics of 5,6-dihydro-4H-4(isobutylamino)thieno(2,3-B)thiopyran-2-sulfonamide-7,7 -dioxide , a potent carbonic anhydrase inhibitor, in rats.
      J H Lin, E H Ulm and L E Los
      Drug Metabolism and Disposition January 1991, 19 (1) 233-238;

  6. Los, L E

    1. Dose-dependent stereopharmacokinetics of 5,6-dihydro-4H-4(isobutylamino)thieno(2,3-B)thiopyran-2-sulfonamide-7,7 -dioxide , a potent carbonic anhydrase inhibitor, in rats.
      J H Lin, E H Ulm and L E Los
      Drug Metabolism and Disposition January 1991, 19 (1) 233-238;

  7. Lotta, T

    1. Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine.
      J Taskinen, T Wikberg, P Ottoila, L Kanner, T Lotta, A Pippuri and R Bäckström
      Drug Metabolism and Disposition January 1991, 19 (1) 178-183;

  8. Lukey, B J

    1. MMB-4 pharmacokinetics in rabbits after intravenous and intramuscular administration.
      C L Woodard and B J Lukey
      Drug Metabolism and Disposition January 1991, 19 (1) 283-284;

M

  1. Makino, Y

    1. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
      K Kikuchi, Y Nagatsu, Y Makino, T Mashino, S Ohta and M Hirobe
      Drug Metabolism and Disposition January 1991, 19 (1) 257-262;

  2. Malspeis, L

    1. Characterization of the urinary metabolites of merbarone in cancer patients.
      J G Supko and L Malspeis
      Drug Metabolism and Disposition January 1991, 19 (1) 263-273;

  3. Manning, R O

    1. Metabolism and disposition of sulfluramid, a unique polyfluorinated insecticide, in the rat.
      R O Manning, J V Bruckner, M E Mispagel and J M Bowen
      Drug Metabolism and Disposition January 1991, 19 (1) 205-211;

  4. Manzione, B M

    1. Observations on the absorption, distribution, metabolism, and excretion of the dopamine (D2) agonist, quinelorane, in rats, mice, dogs, and monkeys.
      B M Manzione, J R Bernstein and R B Franklin
      Drug Metabolism and Disposition January 1991, 19 (1) 54-60;

  5. Marleau, S

    1. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.
      S Marleau, T T Nguyen, P Du Souich, M Bellemare, A De Lean and H Ong
      Drug Metabolism and Disposition January 1991, 19 (1) 194-199;

  6. Marton, J

    1. Chronic stress impairs oxidative metabolism and hepatic excretion of model xenobiotic substrates in the rat.
      G M Pollack, J L Browne, J Marton and L J Haberer
      Drug Metabolism and Disposition January 1991, 19 (1) 130-134;

  7. Mashino, T

    1. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
      K Kikuchi, Y Nagatsu, Y Makino, T Mashino, S Ohta and M Hirobe
      Drug Metabolism and Disposition January 1991, 19 (1) 257-262;

  8. Matta, S G

    1. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
      P R Pentel, D E Keyler, G J Brunn, J M Milavetz, D G Gilbertson, S G Matta and S M Pond
      Drug Metabolism and Disposition January 1991, 19 (1) 24-28;

  9. Matzke, G R

    1. Disposition of the cephalosporin cefepime in normal and renally impaired subjects.
      R H Barbhaiya, C A Knupp, S T Forgue, G R Matzke, C E Halstenson, J A Opsahl and K A Pittman
      Drug Metabolism and Disposition January 1991, 19 (1) 68-73;

  10. Maurizis, J C

    1. Biodistribution and metabolism in rats and mice of bucromarone.
      J C Maurizis, C Nicolas, M Verny, M Ollier, M Faurie, M Payard and A Veyre
      Drug Metabolism and Disposition January 1991, 19 (1) 94-99;

  11. McKay, G

    1. Cis-flupentixol metabolites in rat plasma and bile. The first proof of glutathione conjugation at the exocyclic double bond.
      Y Z Shu, J W Hubbard, G McKay, E M Hawes and K K Midha
      Drug Metabolism and Disposition January 1991, 19 (1) 154-162;
    2. Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugates.
      C J Jackson, J W Hubbard, G McKay, J K Cooper, E M Hawes and K K Midha
      Drug Metabolism and Disposition January 1991, 19 (1) 188-193;

  12. Meese, C O

    1. Identification of thiodiglycolic acid, thiodiglycolic acid sulfoxide, and (3-carboxymethylthio)lactic acid as major human biotransformation products of S-carboxymethyl-L-cysteine.
      U Hofmann, M Eichelbaum, S Seefried and C O Meese
      Drug Metabolism and Disposition January 1991, 19 (1) 222-226;

  13. Meuldermans, W

    1. Study of the placental transfer of cisapride in sheep. Plasma levels in the pregnant ewe, the fetus, and the lamb.
      G Veereman-Wauters, J Monbaliu, W Meuldermans, R Woestenborghs, M Verlinden, J Heykants and C D Rudolph
      Drug Metabolism and Disposition January 1991, 19 (1) 168-172;

  14. Midha, K K

    1. Cis-flupentixol metabolites in rat plasma and bile. The first proof of glutathione conjugation at the exocyclic double bond.
      Y Z Shu, J W Hubbard, G McKay, E M Hawes and K K Midha
      Drug Metabolism and Disposition January 1991, 19 (1) 154-162;
    2. Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugates.
      C J Jackson, J W Hubbard, G McKay, J K Cooper, E M Hawes and K K Midha
      Drug Metabolism and Disposition January 1991, 19 (1) 188-193;

  15. Milavetz, J M

    1. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
      P R Pentel, D E Keyler, G J Brunn, J M Milavetz, D G Gilbertson, S G Matta and S M Pond
      Drug Metabolism and Disposition January 1991, 19 (1) 24-28;

  16. Miller, M G

    1. Xenobiotic metabolizing enzyme activities in rat, mouse, monkey, and human testes.
      K W DiBiasio, M H Silva, L R Shull, J W Overstreet, B D Hammock and M G Miller
      Drug Metabolism and Disposition January 1991, 19 (1) 227-232;

  17. Mispagel, M E

    1. Metabolism and disposition of sulfluramid, a unique polyfluorinated insecticide, in the rat.
      R O Manning, J V Bruckner, M E Mispagel and J M Bowen
      Drug Metabolism and Disposition January 1991, 19 (1) 205-211;

  18. Modi, M W

    1. Dose-dependent and time-dependent pharmacokinetics in the dog after intravenous administration of dextrorphan.
      P A Cleveland, S Teller, V Kachevsky, E Pinili, R Evans and M W Modi
      Drug Metabolism and Disposition January 1991, 19 (1) 245-250;

  19. Monbaliu, J

    1. Study of the placental transfer of cisapride in sheep. Plasma levels in the pregnant ewe, the fetus, and the lamb.
      G Veereman-Wauters, J Monbaliu, W Meuldermans, R Woestenborghs, M Verlinden, J Heykants and C D Rudolph
      Drug Metabolism and Disposition January 1991, 19 (1) 168-172;

  20. Moor, M J

    1. Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. I. Barbiturates.
      S H Steiner, M J Moor and M H Bickel
      Drug Metabolism and Disposition January 1991, 19 (1) 8-14;

  21. Morin, D

    1. [14C]monocrotaline kinetics and metabolism in the rat.
      J E Estep, M W Lamé, D Morin, A D Jones, D W Wilson and H J Segall
      Drug Metabolism and Disposition January 1991, 19 (1) 135-139;

N

  1. Nagatsu, Y

    1. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
      K Kikuchi, Y Nagatsu, Y Makino, T Mashino, S Ohta and M Hirobe
      Drug Metabolism and Disposition January 1991, 19 (1) 257-262;

  2. Narimatsu, S

    1. Mouse hepatic microsomal enzyme that catalyzes oxidation of 11-oxo-delta 8-tetrahydrocannabinol to delta 8-tetrahydrocannabinol-11-oic acid.
      K Watanabe, N Hirahashi, S Narimatsu, I Yamamoto and H Yoshimura
      Drug Metabolism and Disposition January 1991, 19 (1) 218-221;

  3. Newman, R A

    1. In vitro and in vivo murine metabolism of spirogermanium.
      D Garteiz, Z H Siddik and R A Newman
      Drug Metabolism and Disposition January 1991, 19 (1) 44-47;

  4. Nguyen, T T

    1. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.
      S Marleau, T T Nguyen, P Du Souich, M Bellemare, A De Lean and H Ong
      Drug Metabolism and Disposition January 1991, 19 (1) 194-199;

  5. Nicolas, C

    1. Biodistribution and metabolism in rats and mice of bucromarone.
      J C Maurizis, C Nicolas, M Verny, M Ollier, M Faurie, M Payard and A Veyre
      Drug Metabolism and Disposition January 1991, 19 (1) 94-99;

  6. Niemeijer, N R

    1. Glucuronidation of labetalol at the two hydroxy positions by bovine liver microsomes. Isolation, purification, and structure elucidation of the glucuronides of labetalol.
      N R Niemeijer, T K Gerding and R A De Zeeuw
      Drug Metabolism and Disposition January 1991, 19 (1) 20-23;

O

  1. Ohta, S

    1. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
      K Kikuchi, Y Nagatsu, Y Makino, T Mashino, S Ohta and M Hirobe
      Drug Metabolism and Disposition January 1991, 19 (1) 257-262;

  2. Ollier, M

    1. Biodistribution and metabolism in rats and mice of bucromarone.
      J C Maurizis, C Nicolas, M Verny, M Ollier, M Faurie, M Payard and A Veyre
      Drug Metabolism and Disposition January 1991, 19 (1) 94-99;

  3. Ong, H

    1. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.
      S Marleau, T T Nguyen, P Du Souich, M Bellemare, A De Lean and H Ong
      Drug Metabolism and Disposition January 1991, 19 (1) 194-199;

  4. Opsahl, J A

    1. Disposition of the cephalosporin cefepime in normal and renally impaired subjects.
      R H Barbhaiya, C A Knupp, S T Forgue, G R Matzke, C E Halstenson, J A Opsahl and K A Pittman
      Drug Metabolism and Disposition January 1991, 19 (1) 68-73;

  5. Ottoila, P

    1. Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine.
      J Taskinen, T Wikberg, P Ottoila, L Kanner, T Lotta, A Pippuri and R Bäckström
      Drug Metabolism and Disposition January 1991, 19 (1) 178-183;

  6. Overstreet, J W

    1. Xenobiotic metabolizing enzyme activities in rat, mouse, monkey, and human testes.
      K W DiBiasio, M H Silva, L R Shull, J W Overstreet, B D Hammock and M G Miller
      Drug Metabolism and Disposition January 1991, 19 (1) 227-232;

P

  1. Payard, M

    1. Biodistribution and metabolism in rats and mice of bucromarone.
      J C Maurizis, C Nicolas, M Verny, M Ollier, M Faurie, M Payard and A Veyre
      Drug Metabolism and Disposition January 1991, 19 (1) 94-99;

  2. Pentel, P R

    1. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
      P R Pentel, D E Keyler, G J Brunn, J M Milavetz, D G Gilbertson, S G Matta and S M Pond
      Drug Metabolism and Disposition January 1991, 19 (1) 24-28;

  3. Perdu-Durand, E F

    1. Evidence for glucuronidation and sulfation of zeranol and metabolites (taleranol and zearalanone) by rat and pig hepatic subfractions.
      G F Bories, E F Perdu-Durand, J F Sutra and J E Tulliez
      Drug Metabolism and Disposition January 1991, 19 (1) 140-143;

  4. Petersen, D R

    1. The metabolism of 3,7-dimethyl-2,6-octadienal (citral) in rat hepatic mitochondrial and cytosolic fractions. Interactions with aldehyde and alcohol dehydrogenases.
      C S Boyer and D R Petersen
      Drug Metabolism and Disposition January 1991, 19 (1) 81-86;

  5. Pinili, E

    1. Dose-dependent and time-dependent pharmacokinetics in the dog after intravenous administration of dextrorphan.
      P A Cleveland, S Teller, V Kachevsky, E Pinili, R Evans and M W Modi
      Drug Metabolism and Disposition January 1991, 19 (1) 245-250;

  6. Pippuri, A

    1. Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine.
      J Taskinen, T Wikberg, P Ottoila, L Kanner, T Lotta, A Pippuri and R Bäckström
      Drug Metabolism and Disposition January 1991, 19 (1) 178-183;

  7. Pittman, K A

    1. Disposition of the cephalosporin cefepime in normal and renally impaired subjects.
      R H Barbhaiya, C A Knupp, S T Forgue, G R Matzke, C E Halstenson, J A Opsahl and K A Pittman
      Drug Metabolism and Disposition January 1991, 19 (1) 68-73;

  8. Pollack, G M

    1. Chronic stress impairs oxidative metabolism and hepatic excretion of model xenobiotic substrates in the rat.
      G M Pollack, J L Browne, J Marton and L J Haberer
      Drug Metabolism and Disposition January 1991, 19 (1) 130-134;

  9. Pond, S M

    1. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
      P R Pentel, D E Keyler, G J Brunn, J M Milavetz, D G Gilbertson, S G Matta and S M Pond
      Drug Metabolism and Disposition January 1991, 19 (1) 24-28;

R

  1. Radominska, A

    1. Glucuronidation of monohydroxylated short chain bile acids by human liver microsomes and purified human liver UDP-glucuronosyltransferases.
      Y M Irshaid, A Radominska, P Zimniak, A Zimniak, R Lester and T R Tephly
      Drug Metabolism and Disposition January 1991, 19 (1) 173-177;

  2. Reinders, F X

    1. The enzymatic hydrolysis-activation of the adriamycin cardioprotective agent (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane.
      B B Hasinoff, F X Reinders and V Clark
      Drug Metabolism and Disposition January 1991, 19 (1) 74-80;

  3. Reissmann, F

    1. Comparative pharmacokinetics of abecarnil in rat following single and multiple intragastric treatment and continuous administration via the diet.
      W Krause, F Reissmann, W Schunack and C Schöbel
      Drug Metabolism and Disposition January 1991, 19 (1) 29-35;

  4. Remmel, R P

    1. Isolation and characterization of a novel quaternary ammonium-linked glucuronide of lamotrigine.
      M W Sinz and R P Remmel
      Drug Metabolism and Disposition January 1991, 19 (1) 149-153;

  5. Robinson, S P

    1. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.
      S P Robinson, S M Langan-Fahey, D A Johnson and V C Jordan
      Drug Metabolism and Disposition January 1991, 19 (1) 36-43;

  6. Rudolph, C D

    1. Study of the placental transfer of cisapride in sheep. Plasma levels in the pregnant ewe, the fetus, and the lamb.
      G Veereman-Wauters, J Monbaliu, W Meuldermans, R Woestenborghs, M Verlinden, J Heykants and C D Rudolph
      Drug Metabolism and Disposition January 1991, 19 (1) 168-172;

S

  1. Satterwhite, J H

    1. Effects of age and dose on the pharmacokinetics of ibuprofen in the rat.
      J H Satterwhite and F D Boudinot
      Drug Metabolism and Disposition January 1991, 19 (1) 61-67;

  2. Schöbel, C

    1. Comparative pharmacokinetics of abecarnil in rat following single and multiple intragastric treatment and continuous administration via the diet.
      W Krause, F Reissmann, W Schunack and C Schöbel
      Drug Metabolism and Disposition January 1991, 19 (1) 29-35;

  3. Schunack, W

    1. Comparative pharmacokinetics of abecarnil in rat following single and multiple intragastric treatment and continuous administration via the diet.
      W Krause, F Reissmann, W Schunack and C Schöbel
      Drug Metabolism and Disposition January 1991, 19 (1) 29-35;

  4. Seefried, S

    1. Identification of thiodiglycolic acid, thiodiglycolic acid sulfoxide, and (3-carboxymethylthio)lactic acid as major human biotransformation products of S-carboxymethyl-L-cysteine.
      U Hofmann, M Eichelbaum, S Seefried and C O Meese
      Drug Metabolism and Disposition January 1991, 19 (1) 222-226;

  5. Segall, H J

    1. [14C]monocrotaline kinetics and metabolism in the rat.
      J E Estep, M W Lamé, D Morin, A D Jones, D W Wilson and H J Segall
      Drug Metabolism and Disposition January 1991, 19 (1) 135-139;

  6. Shu, Y Z

    1. Cis-flupentixol metabolites in rat plasma and bile. The first proof of glutathione conjugation at the exocyclic double bond.
      Y Z Shu, J W Hubbard, G McKay, E M Hawes and K K Midha
      Drug Metabolism and Disposition January 1991, 19 (1) 154-162;

  7. Shull, L R

    1. Xenobiotic metabolizing enzyme activities in rat, mouse, monkey, and human testes.
      K W DiBiasio, M H Silva, L R Shull, J W Overstreet, B D Hammock and M G Miller
      Drug Metabolism and Disposition January 1991, 19 (1) 227-232;

  8. Siddik, Z H

    1. In vitro and in vivo murine metabolism of spirogermanium.
      D Garteiz, Z H Siddik and R A Newman
      Drug Metabolism and Disposition January 1991, 19 (1) 44-47;

  9. Silva, M H

    1. Xenobiotic metabolizing enzyme activities in rat, mouse, monkey, and human testes.
      K W DiBiasio, M H Silva, L R Shull, J W Overstreet, B D Hammock and M G Miller
      Drug Metabolism and Disposition January 1991, 19 (1) 227-232;

  10. Sinz, M W

    1. Isolation and characterization of a novel quaternary ammonium-linked glucuronide of lamotrigine.
      M W Sinz and R P Remmel
      Drug Metabolism and Disposition January 1991, 19 (1) 149-153;

  11. Smolen, A

    1. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
      K N Gan, A Smolen, H W Eckerson and B N La Du
      Drug Metabolism and Disposition January 1991, 19 (1) 100-106;
    2. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
      A Smolen, H W Eckerson, K N Gan, N Hailat and B N La Du
      Drug Metabolism and Disposition January 1991, 19 (1) 107-112;

  12. Smolowitz, R M

    1. Immunohistochemical localization of cytochrome P-450IA1 induced by 3,3',4,4'-tetrachlorobiphenyl and by 2,3,7,8-tetrachlorodibenzoafuran in liver and extrahepatic tissues of the teleost Stenotomus chrysops (scup).
      R M Smolowitz, M E Hahn and J J Stegeman
      Drug Metabolism and Disposition January 1991, 19 (1) 113-123;

  13. Soong, S J

    1. Circadian variation of fluoropyrimidine catabolic enzymes in rat liver: possible relevance to 5-fluorodeoxyuridine chemotherapy.
      G C Daher, R W Zhang, S J Soong and R B Diasio
      Drug Metabolism and Disposition January 1991, 19 (1) 285-287;

  14. Srigritsanapol, A

    1. Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat.
      P S Hong, A Srigritsanapol and K K Chan
      Drug Metabolism and Disposition January 1991, 19 (1) 1-7;

  15. Staats, D A

    1. Gastrointestinal absorption of xenobiotics in physiologically based pharmacokinetic models. A two-compartment description.
      D A Staats, J W Fisher and R B Connolly
      Drug Metabolism and Disposition January 1991, 19 (1) 144-148;

  16. Stegeman, J J

    1. Immunohistochemical localization of cytochrome P-450IA1 induced by 3,3',4,4'-tetrachlorobiphenyl and by 2,3,7,8-tetrachlorodibenzoafuran in liver and extrahepatic tissues of the teleost Stenotomus chrysops (scup).
      R M Smolowitz, M E Hahn and J J Stegeman
      Drug Metabolism and Disposition January 1991, 19 (1) 113-123;

  17. Steiner, S H

    1. Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. II. Benzodiazepines.
      X Xie, S H Steiner and M H Bickel
      Drug Metabolism and Disposition January 1991, 19 (1) 15-19;
    2. Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. I. Barbiturates.
      S H Steiner, M J Moor and M H Bickel
      Drug Metabolism and Disposition January 1991, 19 (1) 8-14;

  18. Stuhler, J D

    1. Disposition and metabolism of the angiotensin-converting enzyme inhibitor [4S-[4 alpha, 7 alpha, (R*), 12b beta]]-7-[S-(1-ethoxycarbonyl-3- phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo- pyrido[2,1-a][2]benzazepine-4-carboxylic acid in monkeys and dogs.
      H Cheng, J D Stuhler, B R Dorrbecker and W P Gordon
      Drug Metabolism and Disposition January 1991, 19 (1) 212-217;

  19. Supko, J G

    1. Characterization of the urinary metabolites of merbarone in cancer patients.
      J G Supko and L Malspeis
      Drug Metabolism and Disposition January 1991, 19 (1) 263-273;

  20. Sutra, J F

    1. Evidence for glucuronidation and sulfation of zeranol and metabolites (taleranol and zearalanone) by rat and pig hepatic subfractions.
      G F Bories, E F Perdu-Durand, J F Sutra and J E Tulliez
      Drug Metabolism and Disposition January 1991, 19 (1) 140-143;

T

  1. Tanaka, H

    1. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies.
      H Tanaka and T Kaneko
      Drug Metabolism and Disposition January 1991, 19 (1) 200-204;

  2. Taskinen, J

    1. Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine.
      J Taskinen, T Wikberg, P Ottoila, L Kanner, T Lotta, A Pippuri and R Bäckström
      Drug Metabolism and Disposition January 1991, 19 (1) 178-183;

  3. Teller, S

    1. Dose-dependent and time-dependent pharmacokinetics in the dog after intravenous administration of dextrorphan.
      P A Cleveland, S Teller, V Kachevsky, E Pinili, R Evans and M W Modi
      Drug Metabolism and Disposition January 1991, 19 (1) 245-250;

  4. Tephly, T R

    1. Glucuronidation of monohydroxylated short chain bile acids by human liver microsomes and purified human liver UDP-glucuronosyltransferases.
      Y M Irshaid, A Radominska, P Zimniak, A Zimniak, R Lester and T R Tephly
      Drug Metabolism and Disposition January 1991, 19 (1) 173-177;

  5. Trela, B A

    1. Metabolism of dibasic esters by rat nasal mucosal carboxylesterase.
      M S Bogdanffy, C R Kee, C A Hinchman and B A Trela
      Drug Metabolism and Disposition January 1991, 19 (1) 124-129;

  6. Tulliez, J E

    1. Evidence for glucuronidation and sulfation of zeranol and metabolites (taleranol and zearalanone) by rat and pig hepatic subfractions.
      G F Bories, E F Perdu-Durand, J F Sutra and J E Tulliez
      Drug Metabolism and Disposition January 1991, 19 (1) 140-143;

U

  1. Ulm, E H

    1. Dose-dependent stereopharmacokinetics of 5,6-dihydro-4H-4(isobutylamino)thieno(2,3-B)thiopyran-2-sulfonamide-7,7 -dioxide , a potent carbonic anhydrase inhibitor, in rats.
      J H Lin, E H Ulm and L E Los
      Drug Metabolism and Disposition January 1991, 19 (1) 233-238;

V

  1. Veereman-Wauters, G

    1. Study of the placental transfer of cisapride in sheep. Plasma levels in the pregnant ewe, the fetus, and the lamb.
      G Veereman-Wauters, J Monbaliu, W Meuldermans, R Woestenborghs, M Verlinden, J Heykants and C D Rudolph
      Drug Metabolism and Disposition January 1991, 19 (1) 168-172;

  2. Verlinden, M

    1. Study of the placental transfer of cisapride in sheep. Plasma levels in the pregnant ewe, the fetus, and the lamb.
      G Veereman-Wauters, J Monbaliu, W Meuldermans, R Woestenborghs, M Verlinden, J Heykants and C D Rudolph
      Drug Metabolism and Disposition January 1991, 19 (1) 168-172;

  3. Verny, M

    1. Biodistribution and metabolism in rats and mice of bucromarone.
      J C Maurizis, C Nicolas, M Verny, M Ollier, M Faurie, M Payard and A Veyre
      Drug Metabolism and Disposition January 1991, 19 (1) 94-99;

  4. Veyre, A

    1. Biodistribution and metabolism in rats and mice of bucromarone.
      J C Maurizis, C Nicolas, M Verny, M Ollier, M Faurie, M Payard and A Veyre
      Drug Metabolism and Disposition January 1991, 19 (1) 94-99;

W

  1. Waddell, W J

    1. Studies on induction of metabolism of ethyl carbamate in mice by ethanol.
      N Kurata, H E Hurst, R A Kemper and W J Waddell
      Drug Metabolism and Disposition January 1991, 19 (1) 239-240;

  2. Watanabe, K

    1. Mouse hepatic microsomal enzyme that catalyzes oxidation of 11-oxo-delta 8-tetrahydrocannabinol to delta 8-tetrahydrocannabinol-11-oic acid.
      K Watanabe, N Hirahashi, S Narimatsu, I Yamamoto and H Yoshimura
      Drug Metabolism and Disposition January 1991, 19 (1) 218-221;

  3. Weber, W W

    1. Genetic polymorphism of cytochrome P-450-dependent phencyclidine hydroxylation in mice. Comparison of phencyclidine hydroxylation in humans.
      E J Holsztynska, W W Weber and E F Domino
      Drug Metabolism and Disposition January 1991, 19 (1) 48-53;

  4. Wedlund, P J

    1. Stereoselective differences in propranolol disposition in female Sprague-Dawley and Dark Agouti rats.
      R J Guttendorf, H B Kostenbauder and P J Wedlund
      Drug Metabolism and Disposition January 1991, 19 (1) 251-256;
    2. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats.
      H O Hallak and P J Wedlund
      Drug Metabolism and Disposition January 1991, 19 (1) 278-279;

  5. Wikberg, T

    1. Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine.
      J Taskinen, T Wikberg, P Ottoila, L Kanner, T Lotta, A Pippuri and R Bäckström
      Drug Metabolism and Disposition January 1991, 19 (1) 178-183;

  6. Wilson, D W

    1. [14C]monocrotaline kinetics and metabolism in the rat.
      J E Estep, M W Lamé, D Morin, A D Jones, D W Wilson and H J Segall
      Drug Metabolism and Disposition January 1991, 19 (1) 135-139;

  7. Woestenborghs, R

    1. Study of the placental transfer of cisapride in sheep. Plasma levels in the pregnant ewe, the fetus, and the lamb.
      G Veereman-Wauters, J Monbaliu, W Meuldermans, R Woestenborghs, M Verlinden, J Heykants and C D Rudolph
      Drug Metabolism and Disposition January 1991, 19 (1) 168-172;

  8. Woodard, C L

    1. MMB-4 pharmacokinetics in rabbits after intravenous and intramuscular administration.
      C L Woodard and B J Lukey
      Drug Metabolism and Disposition January 1991, 19 (1) 283-284;

X

  1. Xie, X

    1. Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. II. Benzodiazepines.
      X Xie, S H Steiner and M H Bickel
      Drug Metabolism and Disposition January 1991, 19 (1) 15-19;

Y

  1. Yamamoto, I

    1. Mouse hepatic microsomal enzyme that catalyzes oxidation of 11-oxo-delta 8-tetrahydrocannabinol to delta 8-tetrahydrocannabinol-11-oic acid.
      K Watanabe, N Hirahashi, S Narimatsu, I Yamamoto and H Yoshimura
      Drug Metabolism and Disposition January 1991, 19 (1) 218-221;

  2. Yoshimura, H

    1. Mouse hepatic microsomal enzyme that catalyzes oxidation of 11-oxo-delta 8-tetrahydrocannabinol to delta 8-tetrahydrocannabinol-11-oic acid.
      K Watanabe, N Hirahashi, S Narimatsu, I Yamamoto and H Yoshimura
      Drug Metabolism and Disposition January 1991, 19 (1) 218-221;

Z

  1. Zhang, R W

    1. Circadian variation of fluoropyrimidine catabolic enzymes in rat liver: possible relevance to 5-fluorodeoxyuridine chemotherapy.
      G C Daher, R W Zhang, S J Soong and R B Diasio
      Drug Metabolism and Disposition January 1991, 19 (1) 285-287;

  2. Zimniak, A

    1. Glucuronidation of monohydroxylated short chain bile acids by human liver microsomes and purified human liver UDP-glucuronosyltransferases.
      Y M Irshaid, A Radominska, P Zimniak, A Zimniak, R Lester and T R Tephly
      Drug Metabolism and Disposition January 1991, 19 (1) 173-177;

  3. Zimniak, P

    1. Glucuronidation of monohydroxylated short chain bile acids by human liver microsomes and purified human liver UDP-glucuronosyltransferases.
      Y M Irshaid, A Radominska, P Zimniak, A Zimniak, R Lester and T R Tephly
      Drug Metabolism and Disposition January 1991, 19 (1) 173-177;
Back to top

In this issue

Advertisement